CLLS - CIK 0001627281
The table below shows Cellectis S.A.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $23.08M | $23.52M | $22.20M | $25.63M | $31.15M | $22.86M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.08M |
| $3.88M |
| $3.95M |
| $4.83M |
| $9.34M |
| $9.07M |
| Operating income | - | - | - | - | - | - |
| Income tax | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | - | - | - | - | - | - |